Top Markets
#1 SODAX SODAX +58.16%
#2 龙虾 (Lobster) 龙虾 (Lobster) +37.41%
#3 Cortex Cortex +32.76%
#4 DexNet DexNet +23.20%
#5 Pons Pons +21.75%
#6 Akedo Akedo +20.11%
#7 wojak wojak +18.55%
#8 MANTRA MANTRA +14.88%
#9 OpenEden OpenEden +14.07%
#10 APEX APEX +13.93%
Coin of the day
SODAX SODAX
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Chinook Therapeutics, Inc. Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc.

KDNY
Classificação em ações #7141
Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical... Chinook Therapeutics, Inc., a biotechnology enterprise in the clinical development phase, is dedicated to the identification, progression, and market introduction of precise medical treatments for kidney-related conditions. The company's primary therapeutic candidate, atrasentan, is an endothelin receptor antagonist currently in Phase III clinical trials. This drug aims to treat IgA nephropathy and various other glomerular diseases characterized by proteinuria. Beyond its lead program, Chinook's investigational pipeline includes BION-1301, an anti-APRIL monoclonal antibody, which is presently being evaluated in a Phase I/II study for IgA nephropathy. Another promising candidate is CHK-336, an oral small molecule designed to inhibit LDHA, intended for patients with primary hyperoxaluria. The firm also maintains active research initiatives exploring solutions for other uncommon and severe chronic kidney ailments. Chinook Therapeutics, Inc. is based in Seattle, Washington.
Preço da ação
$40.39
Última sincronização: 2023-08-18
Valor de mercado
$1.70B
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Chinook Therapeutics, Inc. (KDNY)

Categoria

Healthcare
Receita da Chinook Therapeutics, Inc. (KDNY)
Receita em Aug 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Chinook Therapeutics, Inc., a receita atual da empresa (TTM) é 0. Em 2026, a empresa obteve uma receita de 0 igual a a receita do ano 2026, que foi de 0. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Chinook Therapeutics, Inc. de 2026 a 2026
Receita no final de cada ano
Ano Receita Alterar
Não há dados suficientes para as datas fornecidas.
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH